Ignite Creation Date:
2024-05-06 @ 8:03 PM
Last Modification Date:
2024-10-26 @ 3:19 PM
Study NCT ID:
NCT06235801
Status:
RECRUITING
Last Update Posted:
2024-06-04
First Post:
2024-01-23
Brief Title:
A Phase III Study of Gilteritinib and Momelotinib for Patients With Relapsed or Refractory FLT3-Mutated Acute Myeloid Leukemia
Sponsor:
Organization:
MD Anderson Cancer Center